Riskpilot← Back to searchSign inGet full accessPharmaca Health Intelligence Oy
OYActiveY-tunnus 9003268-9Korkeavuorenkatu 35Other information service activities · NACE 6392Est. 197851 employees
Revenue 2024
EUR 8M
+10% vs 2023
EBITDA margin
13.6%
-4% vs 2023
Equity ratio
48.0%
Financial strength
Net profit 2024
EUR 1,1M
+2% vs 2023
| Revenue | EUR 8M | +10% |
| EBITDA | EUR 1,1M | -4% |
| Net profit | EUR 1,1M | +2% |
| Total assets | EUR 8,3M | -98% |
| Equity | EUR 4M | -99% |
| Employees | 51 | — |
Legal name
Pharmaca Health Intelligence Oy
Y-tunnus number
9003268-9
Legal form
Osakeyhtiö
NACE code
6392 · Other information service activities
Founded
15. maaliskuuta 1978
Share capital
EUR 20 000
Employees
51 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on lääke- ja terveydenhuoltoalan tietojen, palveluiden ja luetteloiden julkaiseminen, tiedolla johtamisen palvelut ja konsultointi, lääketietokannat, lääkinnälliset laitteet, Saas-palvelut ja näihin liittyvät digitaaliset palvelut, lääke- ja terveydenhuoltoalan koulutustapahtumat ja kauppa näihin liittyvillä palveluilla ja välineillä, lääkkeisiin ja lääkehuoltoon liittyvän sisällön tuottaminen sekä kauppa näihin liittyvillä palveluilla ja välineillä Suomessa ja ulkomailla sekä kaikki muu laillinen liiketoiminta. Lisäksi yhtiö voi omistaa ja hallita kiinteää ja irtainta omaisuutta sekä arvopapereita ja käydä niillä kauppaa.
Address
Korkeavuorenkatu 35
Phone
+3580961504950
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 241 | 6 676 | 7 258 | 7 307 | 8 003 |
| Staff expenses | −2 720 | −3 142 | −3 646 | −3 763 | −1 600 |
| EBITDA | 940 | 1 132 | 948 | 1 131 | 1 089 |
| Depreciation & amort. | −9 | −7 | −5 | −11 | −89 |
| EBIT | 930 | 1 125 | 943 | 1 121 | 1 000 |
| Net financials | 39 | 391 | −64 | 155 | 307 |
| Profit before tax | 970 | 1 516 | 879 | 1 275 | 1 307 |
| Tax | 194 | 303 | 205 | 197 | 209 |
| Net profit | 776 | 1 213 | 674 | 1 078 | 1 098 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 819 | 5 099 | 5 037 | 518 924 | 8 300 |
| Equity | 3 588 | 3 965 | 3 762 | 388 246 | 3 980 |
| Long-term debt | 35 | 42 | 54 | 0 | 0 |
| Short-term debt | 1 196 | 1 092 | 1 221 | 130 678 | 4 319 |
| Total debt | 1 231 | 1 135 | 1 275 | 130 678 | 4 319 |
EBITDA margin
13.6%
This company
15.8%
Market median
-14% vs market
20202024
Equity ratio
48.0%
This company
38.2%
Market median
+26% vs market
20202024
Return on equity
27.6%
This company
18.4%
Market median
+50% vs market
20202024
Net profit margin
13.7%
This company
8.1%
Market median
+69% vs market
20202024
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20202024
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
OO Chief Executive Officer | Chief Executive Officer | 2021 |
RE Confidential Clerk | Confidential Clerk | 2015 |
EE Confidential Clerk | Confidential Clerk | 2015 |
| Audit | 2025 | |
| Former (3) | ||
MK Chief Executive Officer | Chief Executive Officer | 2013 – 2021 |
HM | Audit | 2018 – 2025 |
KM Audit | Audit | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2018 | |
| Board of Directors | 2025 | |
| Board of Directors | 2026 | |
| Chairperson | 2020 | |
| Former (4) | ||
| Chairperson | 2018 – 2020 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2018 – 2024 | |
| Board of Directors | 2018 – 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmaca Health Intelligence Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Minna Kristiina Palhamo | Chief Executive Officer | 0 companies |
| Ouli Onerva Orvokki Uimonen | Chief Executive Officer | 0 companies |
| Heidi Marjatta Vierros | Audit | 0 companies |
| Riitta Elina Mellin | Confidential Clerk | 0 companies |
| Essi Elisabet Kariaho | Confidential Clerk | 0 companies |
| Kirsi Marja Aromäki | Audit | 0 companies |
| Sanna Maria Kristiina Riihentupa | Audit | 0 companies |
| Anne-Mari Virolainen | Board of Directors | 0 companies |
| Päivi Elisa Kerkola | Chairperson | 0 companies |
| Ove Lennart Uljas | Board of Directors | 0 companies |
| Sami Sampsa Johannes Huilla | Board of Directors | 0 companies |
| Jaakko Tapio Linna | Board of Directors | 0 companies |
| Nina Maria Ekholm-Wenberg | Board of Directors | 0 companies |
| Antti Tapio Viitanen | Chairperson | 0 companies |
| Sanna-Liisa Aunesluoma | Board of Directors | 0 companies |
| Jyrki Lauri Liljeroos | Board of Directors | 0 companies |